Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Profit After Tax (2024 - 2026)

Beta Bionics' Profit After Tax history spans 3 years, with the latest figure at -$21.9 million for Q1 2026.

  • On a quarterly basis, Profit After Tax rose 23.59% to -$21.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$66.4 million, a 6.38% increase, with the full-year FY2025 number at -$73.2 million, down 33.68% from a year prior.
  • Profit After Tax hit -$21.9 million in Q1 2026 for Beta Bionics, down from -$13.5 million in the prior quarter.
  • Over the last five years, Profit After Tax for BBNX hit a ceiling of -$9.7 million in Q3 2024 and a floor of -$28.7 million in Q1 2025.
  • Historically, Profit After Tax has averaged -$16.7 million across 3 years, with a median of -$14.5 million in 2024.
  • The widest YoY moves for Profit After Tax: up 25.64% in 2025, down 130.19% in 2025.
  • Tracing BBNX's Profit After Tax over 3 years: stood at -$18.1 million in 2024, then rose by 25.64% to -$13.5 million in 2025, then crashed by 62.59% to -$21.9 million in 2026.
  • Business Quant data shows Profit After Tax for BBNX at -$21.9 million in Q1 2026, -$13.5 million in Q4 2025, and -$14.2 million in Q3 2025.